Kristen Striffler

Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease: the ONSET-2 Phase 3, Randomized Trial.

D. Wirta, P. Vollmer, J. Paauw, 2021, Ophthalmology.

OC-01 (Varenicline Solution) Nasal Spray Demonstrates Consistency of Effect Regardless of Age, Race, Ethnicity, and Artificial Tear Use

M. Macsai, S. Daya, Alice T. Epitropoulos, 2022, Clinical ophthalmology.

Efficacy and Safety of Single-Dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial.

Kristen Striffler, J. Nau, G. Torkildsen, 2022, Clinical therapeutics.